Bibliographic survey of the mechanism of development of Type II Diabetes Mellitus after infection by SARS-COV-2
DOI:
https://doi.org/10.33448/rsd-v11i12.33999Keywords:
Diabetes mellitus type II; SARS-COV-2; Metabolic glucose dysfunction.Abstract
This study aims to conduct a systematic review of the literature to understand the mechanism of development of type II DM after SARS-COV-2 infection and to point out new updates on the subject. Currently, the world faces the pandemic of Coronavirus Disease 2019, a severe acute respiratory syndrome caused by coronavirus SARS-COV-2, having as one of the most frequent pathological consequences diabetes mellitus type II (Type II DM). DM type II is a metabolic endocrine dysfunction characterized by excess circulating glucose in the blood due to defects in the secretion and/or action of insulin, thus hindering the use of glucose as an energy source for the homeostatic metabolic functions of the human body. To date, several epidemiological studies indicate that a high pathological relationship between Covid-19 and DM type II where both pathologies complement each other to generate simultaneous harmful damage. By bringing pancreatic beta cell dysfunction, SARS-COV-2 can induce transient acute hyperglycemia or lead to a genetically predisposed individual developing DM type II. The prevalence of DM type II in patients recovering from post-covid 19 infection is notorious, but new searches to better understand its etiology are crucial.
References
Akter, F., Mannan, A., Mehedi, H. H., Rob, M. A., Ahmed, S., Salauddin, A., Hossain, M. S., & Hasan, M. M. (2020). Clinical characteristics and short term outcomes after recovery from COVID-19 in patients with and without diabetes in Bangladesh. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(06), 2031-2038. doi.org/10.1016/j.dsx.2020.10.016
Anghebem, M. I., Rego, F. G. d. M., & Picheth, G. (2020). COVID-19 e Diabetes: a relação entre duas pandemias distintas. rbac, 52(2), 154-159. doi.org/10.21877/2448-3877.20200001
Bellido, V., & Pérez, A. (2020). Consecuencias de la COVID-19 sobre las personas con diabetes. Endocrinología, Diabetes y Nutrición, 67(6), 355-356. doi.org/10.1016/j.endinu.2020.04.001
Darif, D., Hammi, I., Kihel, A., Saik, I. E. I., Guessous, F., & Akarid, K. (2021). The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong? Microbial Pathogenesis, 153. doi.org/10.1016/j.micpath.2021.104799
Ebinger, J. E., Achamallah, N., Ji, H., Claggett, B. L., Sun, N., Botting, P., & Cheng, S. (2020). Pre-existing traits associated with Covid-19 illness severity. PLOS ONE, 15(7). doi.org/ 10.1371/journal.pone.0236240
Fignani, D., Licata, G., Brusco, N., Nigi, L., Grieco, G. E., Marselli, L., Overbergh, L., Gysemans, C., Colli, M. L., & Marchetti, P. (2020). SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic b-Cells and in the Human Pancreas Microvasculature. Frontiers in endocrinology, 13(11). doi.org/10.3389/fendo.2020.596898
Garces, T. S., Sousa, G. J. B., Cestari, V. R. F., Florêncio, R. S., Damasceno, L. L. V., Pereira, M. L. D., & Moreira, T. M. M. (2022). Diabetes como um fator associado ao óbito hospitalar por COVID-19 no Brasil, 2020. Revista do SUS, 31(1). doi.org/10.1590/S1679-49742022000100021
Lima, B. S., Frota, M. C. M., Ramos, S. P., Pereira, J. L., & Nóbrega, A. d. P. R. (2021). Diabetes mellitus e sua relação com a COVID-19: um panorama atual proveniente de uma revisão sistemática. Research, Society and Development, 10(15). doi.org/http://dx.doi.org/10.33448/rsd-v10i15.22598
Montefusco, L., Ben Nasr, M., D?Addio, F., Loretelli, C., Rossi, A., Pastore, I., Daniele, G., Abdelsalam, A., Maestroni, A., & Dell?Acqua, M. (2021). Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nature Metabolism, 3, 774-785. doi.org/10.1038/s42255-021-00407-6
Müller, J. A., Groß, R., Conzelmann, C., Krüger, J., Merle, U., Steinhart, J., Weil, T., Koepke, L., Bozzo, C. P., & Read, C. (2021). SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nature Metabolism, 3, 149-165. doi.org/10.1038/s42255-021-00347-1
Pal, R., & Bhadada, S. K. (2020). Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? Diabetes Research and Clinical Practice, 163. doi.org/10.1016/j.diabres.2020.108146
Rathmann, W., Kuss, O., & Kostev, K. (2022). Incidence of newly diagnosed diabetes after Covid-19. Diabetologia, 65(6), 949-954. doi.org/10.1007/s00125-022-05670-0
Ruiz, V. J. C., Montes, R. I., Puerta, J. M. P. J. M., Ruiza, C., & Rodrígueza, L. M. (2020). SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Cytokine and Growth Factor Reviews, 54, 62-75. doi.org/10.1016/j.cytogfr.2020.06.001
Sathish, T., Kapoor, N., Cao, Y., Tapp, R. J., & Zimmet, P. (2020). Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis. Wiley, 23(3), 870-874. doi.org/10.1111/dom.14269
Sathisha, T., Tappb, R. J., Cooperd, M. E., & Zimmetd, P. (2021). Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes. Diabetes & Metabolism, 47(2). doi.org/10.1016/j.diabet.2020.10.002
Sen, S., Chakraborty, R., Kalita, P., & Pathak, M. P. (2021). Diabetes mellitus and COVID-19: Understanding the association in light of current evidence. World Journal of W J C C Clinical Cases, 9(28). doi.org/10.12998/wjcc.v9.i28.8327
Shang, J., Wang, Q., Zhang, H., Wang, X., Wan, J., Yan, Y., & Lin, J. (2021). The relationship between diabetes mellitus and COVID-19 prognosis: a retrospective cohort study in Wuhan, China. The American Journal of Medicine, 134(1), 6-14. doi.org/10.1016/j.amjmed.2020.05.033
Tiwari, N. R., Phatak, S., Sharma, V. R., & Agarwal, S. K. (2021). COVID-19 and thrombotic microangiopathies. Thrombosis Research, 202, 191-198. doi.org/10.1016/j.thromres.2021.04.012
Wool, G. D., & Miller, J. L. (2020). The Impact of COVID-19 Disease on Platelets and Coagulation. Pathobiology, 88(1), 15-27. doi.org/10.1159/000512007
Yang, Y., Wei, Z., Xiong, C., & Qian, H. (2022). Direct mechanisms of SARS CoV 2 induced cardiomyocyte damage: an update. Virology, 19(1), 108. doi.org/10.1186/s12985-022-01833-y
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Felipe dos Santos Carvalho; Eliza Caetano Machado; Agnaldo Saraiva Leitão; Dandara Franco Ramos; Laís Túlio Oliveira; Ana Julia Aidar Lima ; Guilherme Stephano Moreira Mendes
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
